The EPA, headquartered in the William Jefferson Clinton Federal Building, says it has enough data on pesticide Nanosilva to know that it’s safe while the manufacturer finishes testing.c_nilsen/Flickr

Tiny particles of silver could appear soon in children’s toys and clothing, embedded inside plastics and fabrics to fight stains and odors.

No one knows how the germ-killing particles, part of a new pesticide called Nanosilva, affect human health or the environment in the long run. But regulators have proposed letting Nanosilva on the market for up to four years before the manufacturer has to submit studies on whether the particles pose certain dangers.

That’s because the U.S. Environmental Protection Agency has backed approving Nanosilva through conditional registration, a fast-track process that recently has drawn criticism for oversight problems. Unlike regular registration, it allows a pesticide to be sold before all required safety studies are in. In this case, manufacturer Nanosilva LLC can move ahead even though it hasn’t explored fully the potential health risks if the product were to seep out of plastic or be inhaled.

Nanosilva’s approval, which could be finalized early this year, has renewed focus on the loophole, designed mainly to help the EPA speed up approvals of pesticides nearly identical to those already being sold.

Recent reviews have found vast problems with the EPA’s oversight of conditional registration. An internal audit showed in 2011 that 70 percent of all active pesticides had been conditionally approved. The audit also concluded that the agency used the label too broadly. Since then, its use has increased. Figures the EPA provided in December put the number at 80 percent.

Thousands of pesticides kept conditional status for more than 20 years, the Natural Resources Defense Council, a nonprofit environmental advocacy group, found in 2010. The EPA says studies typically are due within four years.

And last year, federal auditors found the agency couldn’t reliably track how many products were conditionally registered or whether safety studies were submitted. As a result, pesticides could linger on the market for years without critical tests, the Government Accountability Office warned in August.

These aren’t new problems. At least seven independent reviews dating back to 1980 have noted flaws with the agency’s systems for tracking pesticide registrations.

The EPA said it has enough data on Nanosilva to know that it’s safe while the manufacturer finishes testing, as the law requires. But some scientists and environmentalists say the agency is taking a risk on products that are hardly essential, like sports clothing that doesn’t stain or stink or toys that last longer.

"You could allow some uses that are justified based on human well-being, such as medical implements, but to allow the possibility that nanosilver would be released in plastic on children's toys, and your kid could chew on it and ingest that material before we understand its toxicity – that's unnecessary risk,” said Samuel Luoma, a research ecologist at the University of California, Davis. “It doesn’t make any sense.”

Conventional silver has been used as an antibacterial product for centuries. It releases ions that are deadly for many bacteria and fungi.

Recently, scientists have broken down silver into particles more than 1,000 times smaller than the width of a human hair – some not much wider than a DNA strand. They’re called nanosilver. Nanosilva is just one brand that contains them.

Nanosilver can be embedded directly into plastics, fabrics and other materials. Companies say this helps products last longer. It also allows them to call items antibacterial and attract germ-conscious consumers. Nanosilver needs to be registered as a pesticide because it claims to kill bacteria and other live organisms.

Regular silver is highly toxic to fish and other aquatic life but isn’t usually dangerous for humans. But scientists say nanosilver could pose unique hazards, and they know little about its long-term risks.

Samuel Luoma, a research ecologist at the University of California, Davis, says the EPA is taking a risk by allowing nanosilver to be used in nonessential products before scientific testing is complete.Courtesy of Samuel Luoma

Animal studies show that nanosilver can slip into cells and build up in the brain, heart and other organs. The EPA doesn’t know whether nanosilver causes reproductive harm or cancer because there are no valid studies. Research on animals suggests that it can collect in the male reproductive system, potentially harming fertility, and may cause genetic mutations, which sometimes are linked to cancer.

Scientists have warned that nanosilver may be more toxic than regular silver and act as a carrier for other poisonous chemicals. Besides human health risks, researchers worry that nanosilver could kill fish and disrupt food chains if it makes its way into the environment.

The EPA argues that approving Nanosilva promotes innovation and lets consumers enjoy better products. The agency also says it didn’t give the manufacturer enough time to do safety tests. The EPA didn’t ask for those tests until nearly four years after an independent scientific advisory panel counseled the EPA on how it should evaluate nanosilver in 2009.

And, in evaluating Nanosilva, the EPA ignored some of that panel’s advice.

The scientists told the agency to evaluate every nanosilver product separately. Just because one is safe doesn’t mean others will be, they said. The agency instead figured out many health and environment risks based on studies on particles that were different from those in Nanosilva. The EPA said the tests were “scientifically appropriate.”

Nanosilva officials couldn't be reached for comment.

This isn’t the first time the EPA has conditionally approved pesticides containing nanosilver.

In November, a federal appeals court overturned the approval of two nanosilver products, ruling that the EPA had incorrectly found they posed no risks to toddlers. That decision didn’t affect Nanosilva because the EPA used different calculations in each case.

Regulators still are grappling with how to deal with nanomaterials. While only two companies have asked for EPA approval, hundreds of products containing nanosilver already are on the market, according to an inventory by The Project on Emerging Nanotechnologies.

The EPA also has fast-tracked other controversial pesticides, including ones linked to the collapse of honeybee colonies and tree deaths.

All conditionally registered pesticides meet legal safety standards, the EPA said. The agency said it’s taken steps to prevent staff from coding registrations incorrectly, which it said was the main reason numbers appeared high.

The EPA also has reviewed some conditionally approved products to look for missing data and other problems. But it hasn’t traced the paper trail for all pesticides, as it told federal auditors it would do by last fall.

The EPA also doesn’t have a concrete plan for the main fix auditors prescribed, an automated tracking system to guarantee that studies arrive and get reviewed. Currently, pesticide managers sometimes rely on handwritten notes and memory to keep track.

“Until they figure out the system, they shouldn’t be using conditional registration,” said Mae Wu, an attorney for the Natural Resources Defense Council.

The EPA first told federal auditors it would develop an automated tracking system more than 25 years ago.

This story was edited by Andrew Donohue and copy edited by Nikki Frick and Christine Lee.

Don't miss the next big story.

Republish Our Stories

By Katia SavchukReveal from The Center for Investigative Reporting January 15, 2014

Thanks for your interest in republishing this story. As a nonprofit newsroom, we want to share our work freely with as many people as possible. We only ask that you follow a few guidelines.

You may embed our audio and video content and republish any written story for free under the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 license and will indemnify our content as long as you strictly follow these guidelines:

TEXT

Include this language at the beginning of the story: “This story was produced by Reveal from The Center for Investigative Reporting (link organization name to revealnews.org), a nonprofit news organization. Get their investigations emailed to you directly by signing up at revealnews.org/newsletter.

Our reporter(s) must be bylined. We prefer the following format: By Emmanuel Martinez, Reveal.

Do not change or edit our material, except only to reflect changes in time and location. (For example, “yesterday” can be changed to “last week,” and “Portland, Ore.” to “Portland” or “here.”)

Include all links from the story.

PHOTOS

You can republish Reveal photos only if you run them in or alongside the stories with which they originally appeared, include the original caption, and do not change them.

If you want to run a photo apart from that story, please request specific permission to license by contacting Senior Digital Producer Sam Ward, sward@revealnews.org. Reveal often uses photos we purchase from The Associated Press; those are not available for republication.

DATA

IN GENERAL

We do not compensate anyone who republishes our work. You also cannot sell our material separately or syndicate it.

You can’t republish all of our material wholesale, or automatically; you need to select stories to be republished individually. To inquire about syndication or licensing opportunities, please contact Sam Ward, sward@revealnews.org

If we send you a request to remove our content from your website, you must agree to do so immediately.

FYI, you can grab HTML code for our stories easily. Click on the “Republish this content” link at the bottom of every story. Please do not alter this code.

DO NOT APPLY IF

If you wish to only use portions of the work or create a derivative, you need separate permission and the license and indemnification do not apply. This license only applies to republication of full works.

Additionally, we will not provide indemnification if you are located or publishing outside the United States, but you may contact us to obtain a license and indemnification on a case-by-case basis.